These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5314713)

  • 41. Femoropopliteal occlusion.
    N Engl J Med; 1966 Mar; 274(12):689-90. PubMed ID: 17929346
    [No Abstract]   [Full Text] [Related]  

  • 42. Improved skin blood flow and cutaneous temperature in the foot of a patient with arteriosclerosis obliterans by vasopressin V1 antagonist (OPC21268). A case report.
    Toba K; Ouchi Y; Akishita M; Kozaki K; Ishikawa M; Nagano K; Etoh M; Hashimoto M; Liang J; Ueda N
    Angiology; 1995 Nov; 46(11):1027-33. PubMed ID: 7486224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AN EVALUATION OF THE HEMODYNAMIC RESPONSE OF THE CLAUDICATING EXTREMITY TO EXERCISE.
    STRANDNESS DE; BELL JW
    Surg Gynecol Obstet; 1964 Dec; 119():1237-42. PubMed ID: 14227748
    [No Abstract]   [Full Text] [Related]  

  • 44. The relationship between calf blood flow and ankle blood pressure in patients with intermittent claudication.
    Sumner DS; Strandness DE
    Surgery; 1969 May; 65(5):763-71. PubMed ID: 5777227
    [No Abstract]   [Full Text] [Related]  

  • 45. Arteriographic changes in femoropopliteal arteriosclerosis obliterans. A five-year follow-up study.
    Coran AG; Warren R
    N Engl J Med; 1966 Mar; 274(12):643-7. PubMed ID: 17926375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iloprost and peripheral arterial disease in diabetic patients.
    Vicari AM; Chiesa R; Mari G; Galimberti M; Di Carlo V; Pozza G
    Acta Diabetol Lat; 1991; 28(1):113-4. PubMed ID: 1713729
    [No Abstract]   [Full Text] [Related]  

  • 47. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
    Regenthal R; Voigt H; Reuter W; Preiss R
    Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 49. Heparin and exercise treatment in a patient with arteriosclerosis obliterans.
    Shioji K; Fujita M; Yamada T; Matsuda T; Nohara R; Sasayama S
    Jpn Circ J; 1997 Aug; 61(8):715-8. PubMed ID: 9276778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nicotine consumption and arterial occlusive disease].
    Wilbert L
    Med Klin; 1971 Sep; 66(36):1190-2. PubMed ID: 5096205
    [No Abstract]   [Full Text] [Related]  

  • 51. A TEN YEAR STUDY OF THE EFFECT OF LUMBAR SYMPATHECTOMY ON THE PERIPHERAL CIRCULATION OF PATIENTS WITH ARTERIOSCLEROTIC OCCLUSIVE DISEASE.
    SHAW RS; AUSTEN WG; STIPA S
    Surg Gynecol Obstet; 1964 Sep; 119():486-94. PubMed ID: 14210146
    [No Abstract]   [Full Text] [Related]  

  • 52. [The percutaneous recanalization of arterial obliterations with Dotter's catheter (Dotter's technic)].
    Zeitler E
    Dtsch Med Wochenschr; 1972 Sep; 97(37):1392-4. PubMed ID: 5055727
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
    Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of vascular diseases of the extremities using pentoxifylline].
    Di Perri T
    Ric Clin Lab; 1988; 18 Suppl 2():49-56. PubMed ID: 3073515
    [No Abstract]   [Full Text] [Related]  

  • 55. [Arteriosclerosis obliterans and ozone therapy. Its administration by different routes].
    Romero Valdés A; Blanco González R; Menéndez Cepero S; Gómez Moraleda M; Ley Pozo J
    Angiologia; 1993; 45(5):177-9. PubMed ID: 8285365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Objective evaluation of cyclandelate in treatment of intermittent claudication associated with arteriosclerosis obliterans.
    Ross JV
    Vasc Dis; 1965 Sep; 2(5):300-4. PubMed ID: 5866204
    [No Abstract]   [Full Text] [Related]  

  • 57. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
    Ost CR; Sténson S
    Scand J Clin Lab Invest Suppl; 1967; 99():241-5. PubMed ID: 6056927
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies].
    Tardito E; Trezzi M; Papackaralambus D
    Minerva Cardioangiol; 1970 Dec; 18(12):692-705. PubMed ID: 5532336
    [No Abstract]   [Full Text] [Related]  

  • 59. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 60. [ISCHEMIC NEUROPATHY. NEUROLOGIC DISORDERS IN THE COURSE OF ARTERIAL OCCLUSIVE DISEASES IN THE AREA OF THE EXTREMITIES].
    LINKE H
    Z Gesamte Inn Med; 1964 Mar; 19():209-23. PubMed ID: 14172688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.